-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Maintains Buy on scPharmaceuticals, Lowers Price Target to $12

Benzinga·03/20/2025 14:59:46
Listen to the news
Maxim Group analyst Naz Rahman maintains scPharmaceuticals (NASDAQ:SCPH) with a Buy and lowers the price target from $20 to $12.